Hip stiffness following mixed conformal neutron and photon radiotherapy: a dose-volume relationship. 1996

P J Chuba, and R Sharma, and M Yudelev, and M Duclos, and F Shamsa, and S Giacalone, and C G Orton, and R L Maughan, and J D Forman
Department of Radiation Oncology, Wayne State University, Gershenson Radiation Oncology Center, Detroit, MI 48201-2097, USA.

OBJECTIVE To determine the relationship between dose, volume, and the incidence of hip stiffness in patients who received conformal neutron irradiation for prostate cancer. METHODS A series of dose-searching studies using neutron irradiation for prostate cancer were performed to determine the optimal dose, fraction size, field size, technique, and proportions of photon and neutron dose. Neutron doses ranged from 9 to 20 Gy and photon doses ranged from 0 to 38 Gy. Data were analyzed by using a hip stiffness grading scale. RESULTS Hip stiffness was recorded on follow-up examination in 30% of patients (40 out of 132) treated with fast neutrons or mixtures of fast neutron and photon radiation for prostate cancer. Hip stiffness was categorized as none (Grade 0, 92 patients), mild (Grade 1, 24 patients), moderate (Grade 2, 10 patients), or severe (Grade 3, 6 patients). The incidence of hip stiffness differed significantly by dose and volume in the five dose levels studied (p < 0.001). CONCLUSIONS By using a mixture of conformal neutron and photon irradiation and limiting the total neutron dose to less than 13 Gy, hip stiffness toxicity could be reduced to acceptable levels.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009502 Neutrons Electrically neutral elementary particles found in all atomic nuclei except light hydrogen; the mass is equal to that of the proton and electron combined and they are unstable when isolated from the nucleus, undergoing beta decay. Slow, thermal, epithermal, and fast neutrons refer to the energy levels with which the neutrons are ejected from heavier nuclei during their decay. Neutron
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D011878 Radiotherapy The use of IONIZING RADIATION to treat malignant NEOPLASMS and some benign conditions. Radiotherapy, Targeted,Targeted Radiotherapy,Radiation Therapy,Radiation Therapy, Targeted,Radiation Treatment,Targeted Radiation Therapy,Radiation Therapies,Radiation Therapies, Targeted,Radiation Treatments,Radiotherapies,Radiotherapies, Targeted,Targeted Radiation Therapies,Targeted Radiotherapies,Therapies, Radiation,Therapies, Targeted Radiation,Therapy, Radiation,Therapy, Targeted Radiation,Treatment, Radiation
D011879 Radiotherapy Dosage The total amount of radiation absorbed by tissues as a result of radiotherapy. Dosage, Radiotherapy,Dosages, Radiotherapy,Radiotherapy Dosages
D004307 Dose-Response Relationship, Radiation The relationship between the dose of administered radiation and the response of the organism or tissue to the radiation. Dose Response Relationship, Radiation,Dose-Response Relationships, Radiation,Radiation Dose-Response Relationship,Radiation Dose-Response Relationships,Relationship, Radiation Dose-Response,Relationships, Radiation Dose-Response
D006615 Hip The projecting part on each side of the body, formed by the side of the pelvis and the top portion of the femur. Coxa,Coxas,Hips
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

P J Chuba, and R Sharma, and M Yudelev, and M Duclos, and F Shamsa, and S Giacalone, and C G Orton, and R L Maughan, and J D Forman
November 1999, International journal of radiation oncology, biology, physics,
P J Chuba, and R Sharma, and M Yudelev, and M Duclos, and F Shamsa, and S Giacalone, and C G Orton, and R L Maughan, and J D Forman
January 1996, Bulletin du cancer. Radiotherapie : journal de la Societe francaise du cancer : organe de la societe francaise de radiotherapie oncologique,
P J Chuba, and R Sharma, and M Yudelev, and M Duclos, and F Shamsa, and S Giacalone, and C G Orton, and R L Maughan, and J D Forman
January 1995, Medical dosimetry : official journal of the American Association of Medical Dosimetrists,
P J Chuba, and R Sharma, and M Yudelev, and M Duclos, and F Shamsa, and S Giacalone, and C G Orton, and R L Maughan, and J D Forman
July 1996, International journal of radiation oncology, biology, physics,
P J Chuba, and R Sharma, and M Yudelev, and M Duclos, and F Shamsa, and S Giacalone, and C G Orton, and R L Maughan, and J D Forman
August 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,
P J Chuba, and R Sharma, and M Yudelev, and M Duclos, and F Shamsa, and S Giacalone, and C G Orton, and R L Maughan, and J D Forman
March 2001, International journal of radiation oncology, biology, physics,
P J Chuba, and R Sharma, and M Yudelev, and M Duclos, and F Shamsa, and S Giacalone, and C G Orton, and R L Maughan, and J D Forman
January 1977, Medical physics,
P J Chuba, and R Sharma, and M Yudelev, and M Duclos, and F Shamsa, and S Giacalone, and C G Orton, and R L Maughan, and J D Forman
August 1995, International journal of radiation oncology, biology, physics,
P J Chuba, and R Sharma, and M Yudelev, and M Duclos, and F Shamsa, and S Giacalone, and C G Orton, and R L Maughan, and J D Forman
October 2002, Physics in medicine and biology,
P J Chuba, and R Sharma, and M Yudelev, and M Duclos, and F Shamsa, and S Giacalone, and C G Orton, and R L Maughan, and J D Forman
November 2017, Radiation protection dosimetry,
Copied contents to your clipboard!